Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Torrent Pharmaceuticals Limited | Indrad, India | Makes it, makes the active ingredient, tests it and packages it | Problems found, fixed voluntarilyJun 12, 2024 · 7 inspections, 2 with FDA action |
| Torrent Pharmaceuticals Limited | Bharuch, India | Makes it, tests it and packages it | No problems foundJan 23, 2026 · 5 inspections, 1 with FDA action |
Recalls
- Nov 25, 2020 · Class I · Torrent Pharma Inc
Failed Dissolution Specifications
Lots: Batch BFD1G001, exp 12/2021 - Sep 6, 2019 · Class II · Torrent Pharma Inc.
Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.
Lots: Lot #: BFE2E003, Exp 08/31/2020
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Anagrelide: every company that makes it
- Form
- capsule, oral
- Strength
- 0.5 mg
- Approval
- ANDA ANDA209151
- On the market since
- Jun 30, 2017
- Package NDCs
13668-453-0113668-453-30- Official label
- DailyMed (National Library of Medicine), updated Aug 17, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?